The full scope of pharmacy practice offers a transformative approach to health care delivery, promising improved patient outcomes, greater access to care, and efficient utilization of health care resources.
Topical corticosteroids are available over the counter and are prescribed for a variety of skin ailments ranging from mild and irritating to severe and debilitating.
This article details what pharmacists need to know about the FDA's new proposed rule on pregnancy and lactation labeling.
A decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.
An overview of the utilization and cost for selected oral antineoplastic agents, with discussion regarding oncology in general, as well as the topic of adherence.
Pharmacists need to be experts on follow-on biologics, including biosimilars, so they can provide education to health professionals about safe prescribing and use.
Pharmacy students who are interested in applying for residency enter into the colloquially termed “Match” program.
Due to the increasing rise in drug abuse from opioids and recent safety warnings regarding NSAIDs, practitioners are beginning to show more interest in topical agents.
Ongoing shortages of common oncology chemotherapies have compelled physicians to substitute more expensive drugs, delay or suspend clinical trials, or even skip doses of chemotherapy, according to survey results presented at ASCO.
Buprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.
Pharmacists should be knowledgeable about the different approaches used to modify biopharmaceuticals and how they affect stability, dosing, safety, and efficacy.
Pharmacists should understand the facts, misconceptions, and myths about pertussis.
Driven by the graying of America, more than 75% of all newly diagnosed cancers occur in people aged 55 or older. Oncology—and oncology pharmacists—are changing hats swiftly.
Moving erlotinib from formulary tier 3 to tier 2 resulted in lower copayments and higher treatment persistence among lung cancer patients.
This drug is a novel single-entity tablet, combining a dihydropyridine calcium channel blocker and an angiotensin receptor blocker.
At the population level, comparative effectiveness research can inform policies and incentives that result in improvements in health and minimize risk.
Resulting economic decline Is forces many to make hard choices about medications, but pharmacists can increase awareness and offer solutions.
Dr. Ford is a clinical pharmacy specialist, University of North Carolina Hospitals, Departments of Pharmacy and Family Medicine.
Drug-related problems such as overdose and drug-drug interactions frequently occur in patient populations at risk for polymorbidity and polypharmacy. Among these problems is proton pump inhibitor (PPI) misuse.
Pharmacy students who are interested in applying for residency enter into the colloquially termed “Match” program.
Labeling, seals of approval, and ingredients should be considered when counseling patients about dietary supplements.
Within the evolving value-based care environment, there is great opportunity for specialty pharmacies to help support this new payer transformation.
Pharmacists are now core members of the vaccination community, playing a role in vaccine accessibility, opportunity, identification, and safety.
In a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.